Clinical trial

Short-term Effects of Dapagliflozin on Peak VO2 in HFrEF

NCT04197635

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-06-01

PhasePHASE4

Study timeline

Study start (actual)2019-06-01Date precision: day

Registry last updated2022-04-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failure With Reduced Ejection Fractionunresolved

Interventions

Maximal functional capacity by cardiopulmonary exercise testingDIAGNOSTIC_TEST

EchocardiographyDIAGNOSTIC_TEST

Evaluation of health related quality of lifeBEHAVIORAL

Submáximal functional capacity assesment by 6 minutes walk testDIAGNOSTIC_TEST

Clinical evaluationOTHER

Sponsors & collaborators

Fundación para la Investigación del Hospital Clínico de Valencialead sponsor

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04197635 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.